Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
RemedyBio logo — Remedy is creating a revolution in immune therapeutics thoug...

RemedyBio

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and disease biology

Founded 2017 Ireland Ireland 7 employees Venture round Total: $10.50M Biotechnology, Health and Wellness

General Information

Company Name RemedyBio
Founded Year 2017
Location Ireland Ireland
Founders / Decision Makers
Team member
Employees 7
Industries Biotechnology, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with RemedyBio. To contact RemedyBio, visit remedybiologics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RemedyBio compare?

A PDF of RemedyBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RemedyBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RemedyBio

RemedyBio is a Dublin-based biotech company leveraging nanoscale technology to revolutionize immune therapeutics. Specializing in immuno-oncology, autoimmune diseases, and infectious diseases, the company's innovative approach involves the analysis of 10M-1Bn cells individually, significantly advancing single-cell research. Conducting combinational biology at scale, RemedyBio simultaneously analyzes healthy tissue, disease biology, and immunological function, providing a comprehensive understanding of diseases. Their advanced methodology involves statistical and machine analysis of millions or billions of cells, including those from patient tumor biopsies. Additionally, RemedyBio offers services for therapeutic design and long-term asset building, including sequencing, replicating, and banking post-assay biology. Established in 2017, the company recently secured a significant €8.00M Venture Round investment from The European Innovation Council on 20 July 2021.

Business keywords: biotech, nanoscale technology, therapeutic research, immuno-oncology, autoimmune diseases, infectious diseases, cell analysis, immune system, diagnostic research, single-cell research, combinational biology, immunological function, therapeutic design, immune therapeutics, Dublin

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €8.00M 1
European Innovation Council
European Innovation Council
20 Jul 2021
Grant €2.50M 1
European Innovation Council
European Innovation Council
01 Jun 2020

RemedyBio Alternatives & Competitors

View All Alternatives
RemedyBio vs
Immunaeon
Immunaeon United States

Connecting Today's Science to Tomorrow's Cures

5 employees
Biopharma, Biotechnology
RemedyBio vs
Serpin Pharma
Serpin Pharma United States

Enhancing cell resilience: A revolutionary approach for inflammatory diseases

Grant
8 employees
Biotechnology, Health Care
RemedyBio vs
Nuvig Therapeutics Inc.
Nuvig Therapeutics Inc. United States

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

Series A
24 employees
Biotechnology, Health Care
View all alternatives

FAQ About RemedyBio

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and disease biology
RemedyBio was founded in 2017.
RemedyBio is headquartered in Ireland.
RemedyBio operates in Biotechnology and Health and Wellness. Its work centres on biotech, nanoscale technology, therapeutic research and immuno-oncology.
RemedyBio has approximately 7 employees.
RemedyBio has completed 2 funding rounds, raising a total of $10.50M. The latest funding stage is Venture round.
Top alternatives and competitors to RemedyBio include Immunaeon, Serpin Pharma, Nuvig Therapeutics Inc., Precigen, Merus N.V.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RemedyBio and Immunaeon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RemedyBio, https://bouncewatch.com/company/remedybio, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout